N-Fmoc-(S)-2,6-difluoro-alpha-methylphenylalanine is a non-natural, fluorinated amino acid derivative. Its structure features an Fmoc (9-fluorenylmethoxycarbonyl) protecting group on the amine, an alpha-methyl group (making it an alpha,alpha-disubstituted amino acid), and a phenyl ring substituted with fluorine atoms at the 2 and 6 positions. This specific substitution pattern creates steric hindrance and introduces unique electronic properties. This compound is primarily used as a specialized building block in solid-phase peptide synthesis (SPPS). The Fmoc group is a standard protecting group that can be removed under mild basic conditions. The incorporation of this fluorinated, alpha-methylated phenylalanine analogue into peptide sequences is a key strategy in medicinal chemistry and chemical biology. It is designed to enhance the metabolic stability, binding affinity, and overall pharmacological profile of therapeutic peptides by modulating their conformation, lipophilicity, and resistance to enzymatic degradation. The presence of fluorine atoms and the alpha-methyl group makes this amino acid a valuable tool for probing structure-activity relationships (SAR) and for developing peptide-based drugs targeting various diseases, including metabolic disorders and cancers. It is a high-value research chemical supplied to pharmaceutical and biotechnology research laboratories.